HBK Investments L P Buys Shares of 155,186 Integer Holdings Corporation $ITGR

HBK Investments L P bought a new stake in Integer Holdings Corporation (NYSE:ITGR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 155,186 shares of the medical equipment provider’s stock, valued at approximately $14,502,000.

Other large investors have also made changes to their positions in the company. Dimensional Fund Advisors LP grew its stake in shares of Integer by 6.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,484,396 shares of the medical equipment provider’s stock valued at $130,620,000 after purchasing an additional 90,277 shares during the period. Irenic Capital Management LP bought a new position in shares of Integer in the 4th quarter worth approximately $99,109,000. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of Integer by 1,141.6% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 819,046 shares of the medical equipment provider’s stock worth $72,076,000 after purchasing an additional 753,081 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Integer by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 832,911 shares of the medical equipment provider’s stock worth $65,336,000 after buying an additional 3,664 shares during the last quarter. Finally, The Manufacturers Life Insurance Company purchased a new position in shares of Integer in the second quarter worth approximately $50,925,000. 99.29% of the stock is currently owned by institutional investors.

Insider Activity

In other news, insider Andrew Senn sold 9,408 shares of the stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $126.30, for a total value of $1,188,230.40. Following the completion of the sale, the insider directly owned 5,405 shares of the company’s stock, valued at $682,651.50. This represents a 63.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.10% of the stock is currently owned by company insiders.

Integer Stock Performance

Shares of NYSE:ITGR traded up $0.01 during mid-day trading on Wednesday, reaching $126.22. 1,124,095 shares of the company traded hands, compared to its average volume of 775,637. The company’s 50 day moving average price is $115.55 and its 200-day moving average price is $97.92. The firm has a market cap of $4.29 billion, a PE ratio of 34.49, a PEG ratio of 2.40 and a beta of 0.62. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $126.79.

Integer (NYSE:ITGR) last released its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.38 by $0.22. Integer had a net margin of 6.97% and a return on equity of 12.79%. The company had revenue of $464.11 million for the quarter, compared to analysts’ expectations of $451.07 million. During the same quarter last year, the business earned $1.55 EPS. The firm’s revenue was down 2.6% compared to the same quarter last year. On average, equities analysts expect that Integer Holdings Corporation will post 6.09 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Wells Fargo & Company upped their target price on shares of Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a report on Tuesday, August 4th. Truist Financial cut shares of Integer from a “buy” rating to a “hold” rating and lifted their price target for the stock from $110.00 to $127.00 in a research note on Monday, August 3rd. Piper Sandler downgraded shares of Integer from an “overweight” rating to a “hold” rating and set a $127.00 price objective for the company. in a research report on Monday, August 3rd. Raymond James Financial lowered Integer from a “moderate buy” rating to a “hold” rating in a research note on Monday, August 3rd. Finally, HC Wainwright restated a “buy” rating on shares of Integer in a research note on Friday, July 24th. One analyst has rated the stock with a Buy rating and thirteen have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $109.86.

Integer Company Profile

Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.

Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.